Month: March 2024

US government will test ibogaine as an addiction treatment

When one typically thinks of psychedelics, the word “trip” is top of mind. Ibogaine has proven effective at treating addiction to tobacco, alcohol, and drugs. Yet, for those naysayers that continue to doubt the treatment based on the fact a “trip” is part of the equation, Will Yakowicz delivers a fascinating story on professor David Olson and his pursuit of a “no-trip” treatment.

In addition to being a faculty member at the University of California at Davis, Olson is also the co-founder of Delix, a company attempting to remove the “trip” from psychedelics while still preserving their therapeutic components. The company’s Delix-7 is said to do just that with ibogaine.

Olson is partial to a theory that the psychedelic trip is not necessary to treat the common addictions that ibogaine treats. The most important part, according to Olson, is the development of neuroplasticity which helps the brain form new neural connections in a positive way.

More research is needed, but this is indeed a promising line of research.

Read the full article here: https://www.forbes.com/sites/willyakowicz/2021/12/07/us-government-will-test-ibogaine-as-an-addiction-treatment

Missouri patients could use psychedelic treatments under new gop right to try bill

In “Missouri Patients Could Use Psychedelic Treatments Under New GOP ‘Right-To-Try’ Bill,” journalist Kyle Jaeger drops some counter-intuitive facts – multiple Republican lawmakers in the Show-Me State are advancing bills to grant legal access to psychedelics such as LSD, psilocybin, and ibogaine. By access, Jaeger explains this is for folks with serious illnesses. Yet, the fact these are Republican lawmakers (as opposed to the usual Democrat suspects) has certainly piqued much interest.

In line with a federal right-to-try law passed back in 2018, the Missouri bill would essentially align the state statute with the federal one. Existing law applies to patients with terminal illnesses. The new law would expand access to those with life-threatening and debilitating conditions. 

An unlikely movement is afoot in middle America with a traditionally conservative party in the driver’s seat. Who would have guessed it!

Read the full article here:

Psychedelic ibogaine addiction recovery opioid

Only 5 to 10 percent of those with an opioid addiction successfully quit via conventional methods. To put that into perspective, in a room with 100 folks, only 5 to 10 will eventually achieve sobriety. A stunning 90 to 95 will remain mired in their addiction.

There must be another route, thought Dimitri H. In a riveting Rolling Stone piece by Jonathan Reiss, we are introduced to Dimitri and his 20 plus years of heroin addiction. After experimenting with the typical treatments, Dimitri booked a trip to Greece to bid farewell to his ancestral homeland and take his own life. But a last-minute stop in the Netherlands and an experimental treatment with ibogaine literally changed everything.

Today Dimitri is helping to treat thousands of opioid addicts whom conventional treatments have failed. He is a self-proclaimed “wounded warrior,” and based on the Alcoholics Anonymous program Dimitri has created a new program that is having great success.

Read full article here: https://www.rollingstone.com/culture/culture-features/psychedelic-ibogaine-addiction-recovery-opioid-dimitri-aa-1161882

Colorado psilocybin dmt ibogaine

Colorado now joins a handful of states in advancing mental health treatment with previously banned substances. Bill HB22-1116 would establish “a policy review panel to study plant-based medicines to support mental health.” As author Nick Wills details in, “Colorado bill would study these natural hallucinogens,” psilocybin, psilocyn, dimethyltrytamine, and igobaine would be the eligible plants should the bill become law. 

Colorado has a history with similar decriminalization. In 2019 mushrooms with psilocybin were decriminalized where much research has shown the positive affect psilocyn has on serotonin, a hormone that affects our digestion, sleep, and mood. Ibogaine has yielded exceptional results with those addicted to opioids. 

In terms of next steps, the legislation will be reviewed by the Public & Behavioral Health and Human Services Committee in February 2022.

Read full article here: https://kdvr.com/news/local/colorado-psilocybin-dmt-ibogaine/

Revolutionizing Addiction Treatment: The Role of Ibogaine and Casa Santa Isabel’s Pioneering Efforts

In a groundbreaking shift within the realm of addiction treatment, ibogaine, a naturally occurring psychoactive substance found in the African iboga plant, is making headlines for its potential to significantly disrupt traditional approaches to opioid addiction recovery. A recent article in the New York Times highlights the growing interest in ibogaine’s unique ability to alleviate withdrawal symptoms and reduce cravings, offering hope to those trapped in the cycle of addiction.

Amidst the burgeoning field of psychedelic-assisted therapies, Casa Santa Isabel, located in the picturesque Baja California, Mexico, emerges as a beacon of hope and innovation. As one of the most respected and legitimate clinics for ibogaine therapy in Mexico, Casa Santa Isabel has dedicated itself to harnessing the transformative power of ibogaine under the guidance of licensed medical professionals.

The clinic’s approach is deeply rooted in scientific research and holistic care, ensuring that each treatment is tailored to the individual’s needs, providing not just a temporary reprieve but a profound, life-altering experience. With a focus on safety, compassion, and efficacy, Casa Santa Isabel stands at the forefront of ibogaine therapy, contributing to the growing body of evidence supporting its effectiveness in addiction treatment.

Ibogaine therapy at Casa Santa Isabel is not merely about substance cessation; it’s a comprehensive journey towards healing and self-discovery. Patients are supported through a meticulously structured program that addresses the psychological, physical, and spiritual facets of addiction, fostering an environment where profound transformation can occur.

As the world begins to recognize the potential of psychedelic-assisted therapies, Casa Santa Isabel’s work with ibogaine offers a compelling case study in the power of alternative treatments. The clinic’s commitment to research, patient care, and therapeutic innovation has solidified its status as a leading figure in the global movement towards more effective and compassionate addiction treatment solutions.

For those seeking a path out of addiction, Casa Santa Isabel represents a fusion of cutting-edge therapy and heartfelt care, embodying the promise of a future where healing and hope are within reach for everyone affected by opioid addiction.